GlassScriptPhysician profile
Lilee Robinson
NPI 1174244602
$914.42
in general payments reported to CMS, 2019-2025
15 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.78 · 2023: $552 · 2024: $90.94 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $252.80 | 2022-2023 | Breztri, Farxiga |
| Corcept Therapeutics | $175.92 | 2023 | Korlym |
| Novo Nordisk INC | $96.82 | 2023-2025 | Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.37 | 2024-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $57.48 | 2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Alkermes, INC. | $45.23 | 2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $38.84 | 2023 | Invega Sustenna |
| Abbvie INC. | $30.50 | 2023 | |
| Exact Sciences Corporation | $28.30 | 2024 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $25.46 | 2024 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $25.16 | 2023 | |
| Vanda Pharmaceuticals INC. | $21.69 | 2025 | Fanapt |
| Xeris Pharmaceuticals, INC. | $21.22 | 2024 | Recorlev |
| Organon LLC | $18.55 | 2022 | |
| Dexcom, INC. | $16.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lilee Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.